Axio Biosolutions
Axio Biosolutions specializes in advanced wound care and haemostatic products, including Axiostat and MaxioCel, used in over 50 countries.
Services
Axio Biosolutions specializes in creating advanced medical solutions for wound care and haemostasis. The company offers a comprehensive range of products designed to cater to emergency trauma, surgical procedures, and chronic wound management. Axio Biosolutions employs cutting-edge technologies to develop its products, ensuring they meet high healthcare standards.
Products
Axio Biosolutions' product portfolio includes innovative solutions such as Axiostat and MaxioCel. Axiostat is a haemostatic dressing that has received USFDA 510(k) clearance and CE approval, making it suitable for various emergency and surgical applications. MaxioCel is another advanced product designed for managing chronic wounds such as diabetic foot ulcers, pressure ulcers, and burns. The company leverages Protonated Bioadhesive Technology (PBT) and Bioactive Microfiber Gelling Technology (BMG) in their products to enhance their efficacy.
Technology
Axio Biosolutions employs advanced technologies like Protonated Bioadhesive Technology (PBT) and Bioactive Microfiber Gelling Technology (BMG) to develop its medical devices. These technologies enable the creation of highly effective products for wound care and haemostasis. PBT helps in rapid adhesion and haemostasis, whereas BMG aids in superior wound management through bioactivity and effective gelling.
Manufacturing Standards
Axio Biosolutions operates a state-of-the-art manufacturing facility that adheres to stringent industry standards. The facility is certified under ISO 13485:2016 and complies with Good Manufacturing Practices (GMP). This ensures that all products meet high-quality benchmarks suitable for international markets.
Global Presence
Axio Biosolutions has a significant global footprint, with its products being used in over 50 countries. The wide usage of its products testifies to the company's commitment to quality and innovation in the healthcare sector, particularly in the fields of trauma, surgical care, and chronic wound management.